LSV ASSET MANAGEMENT

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1050470 CHICAGO, IL

Position in HRMY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$75,049,821

+$18,325,566 QoQ

Shares Held

2,061,242

+1.8% QoQ

Ownership

3.54%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

of 328 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 61% Shared 0% None 39%

Healthcare · as of Jun 30, 2026

LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. HRMY ranks #6 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,275,145	$548,241,690
2	INCY	Incyte Corp	4,123,759	$467,469,320
3	EXEL	Exelixis, Inc.	8,146,478	$443,249,867
4	REGN	Regeneron Pharmaceuticals, Inc.	253,200	$157,880,328
5	HALO	Halozyme Therapeutics, Inc.	1,410,257	$110,380,815
6	HRMY	Harmony Biosciences Holdings, Inc. This page	2,061,242	$75,049,821
7	BMRN	Biomarin Pharmaceutical Inc	881,700	$50,450,874
8	RIGL	Rigel Pharmaceuticals Inc	721,666	$28,231,573

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$75,049,821	2,061,242	+1.8%	Shares	Sole	2026-08-06
2026-03-31	$56,724,255	2,025,143	+22.2%	Shares	Sole	2026-05-11
2025-12-31	$62,008,420	1,657,093	+3.9%	Shares	Sole	2026-02-06
2025-09-30	$43,955,251	1,594,893	+7.1%	Shares	Sole	2025-11-06
2025-06-30	$47,036,663	1,488,502	+24.6%	Shares	Sole	2025-08-11
2025-03-31	$39,660,755	1,194,961	+25.0%	Shares	Sole	2025-05-09
2024-12-31	$32,903,426	956,217	+23.8%	Shares	Sole	2025-02-13
2024-09-30	$30,887,640	772,191	+33.5%	Shares	Sole	2024-11-12
2024-06-30	$17,445,681	578,246	+72.5%	Shares	Sole	2024-08-06
2024-03-31	$11,254,202	335,146	+346.5%	Shares	Sole	2024-05-06
2023-12-31	$2,424,211	75,053	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.